[ESPR] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
12-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -63.27%
YoY- -118.60%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/03 30/06/02 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -14,035 -12,395 -9,238 -6,921 -3,166 -8,435 -7,824 4.25%
Tax 494 337 18 112 304 922 888 -4.09%
NP -14,035 -12,395 -9,238 -6,921 -3,166 -8,435 -7,824 4.25%
Tax Rate - - - - - - - -
Total Cost 14,035 12,395 9,238 6,921 3,166 8,435 7,824 4.25%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/03 30/06/02 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/03 30/06/02 CAGR
EPS -0.62 -0.55 -0.60 -0.47 -0.33 -2.00 -1.87 -7.57%
EPS Diluted -0.62 -0.55 -0.60 -0.47 -0.33 -2.00 -1.87 -7.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.